AP852A - Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby. - Google Patents

Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby. Download PDF

Info

Publication number
AP852A
AP852A APAP/P/1997/001151A AP9701151A AP852A AP 852 A AP852 A AP 852A AP 9701151 A AP9701151 A AP 9701151A AP 852 A AP852 A AP 852A
Authority
AP
ARIPO
Prior art keywords
substance
solvent
fgms
syrup
glass matrix
Prior art date
Application number
APAP/P/1997/001151A
Other languages
English (en)
Other versions
AP9701151A0 (en
Inventor
Bruce Joseph Roser
Edna Martin Gribbon
Original Assignee
Quadrant Holdings Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP852(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadrant Holdings Cambridge Ltd filed Critical Quadrant Holdings Cambridge Ltd
Publication of AP9701151A0 publication Critical patent/AP9701151A0/xx
Application granted granted Critical
Publication of AP852A publication Critical patent/AP852A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
APAP/P/1997/001151A 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby. AP852A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07
PCT/GB1996/001367 WO1996040077A2 (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Publications (2)

Publication Number Publication Date
AP9701151A0 AP9701151A0 (en) 1998-01-31
AP852A true AP852A (en) 2000-06-16

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/001151A AP852A (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby.

Country Status (22)

Country Link
EP (1) EP0831790B1 (no)
JP (1) JP4502406B2 (no)
KR (1) KR19990022710A (no)
CN (1) CN1245957C (no)
AP (1) AP852A (no)
AT (1) ATE239451T1 (no)
AU (1) AU713599B2 (no)
BR (1) BR9609188A (no)
CA (1) CA2223438C (no)
CZ (1) CZ391297A3 (no)
DE (1) DE69628007T2 (no)
DK (1) DK0831790T3 (no)
ES (1) ES2194992T3 (no)
HU (1) HUP9901716A3 (no)
IL (1) IL122482A (no)
MX (1) MX9709716A (no)
NO (1) NO975773L (no)
NZ (1) NZ309841A (no)
PL (1) PL184823B1 (no)
PT (1) PT831790E (no)
SK (1) SK167597A3 (no)
WO (1) WO1996040077A2 (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1188171C (zh) 1994-06-02 2005-02-09 廓德伦特控股剑桥有限公司 防止各种特质在再水化或熔化时聚集的方法以及由此获得的组合物
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
AU5459698A (en) * 1997-11-26 1999-06-15 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
AU2945199A (en) * 1998-03-18 1999-10-11 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
BR0010249A (pt) * 1999-05-04 2002-02-13 Eric Edward Worrall Processo para a preservação de vìrus e micoplasma
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
EP1402003A4 (en) * 1999-08-19 2004-07-14 Universal Preservation Technologies Inc STORAGE OF AMBIENT TEMPERATURE BACTERIAL CELLS
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CZ301813B6 (cs) 2000-06-27 2010-06-30 F. Hoffmann-La Roche Ag Zpusob prípravy farmaceutické kompozice
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
CA2466641A1 (en) * 2001-11-09 2003-05-22 Centocor, Inc. Lyophilized monoclonal antibody compositions
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
DK2395073T3 (en) * 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying.
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
CA2567720A1 (en) * 2004-05-24 2005-12-08 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form
CA2569276C (en) 2004-06-02 2018-01-23 Victor Bronshtein Preservation by vaporization
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP2117354B1 (en) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. A dry food product containing live probiotic
KR101540920B1 (ko) 2007-07-26 2015-08-03 사노피 파스퇴르 리미티드 항원-애주번트 조성물 및 방법
US8283165B2 (en) 2008-09-12 2012-10-09 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
EP2410996B1 (en) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
SG176253A1 (en) 2009-05-26 2011-12-29 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
LT2603100T (lt) * 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Stabilizuojanti kompozicija, skirta biologinių medžiagų sausam saugojimui
RU2013143149A (ru) * 2011-02-24 2015-03-27 Пэксвэкс, Инк. Составы, пригодные для вакцин, получаемых сушкой распылением
CN107625958A (zh) * 2011-05-17 2018-01-26 索利吉尼克斯公司 热稳定性疫苗组合物及其制备方法
IN2014CN03555A (no) 2011-10-25 2015-07-03 Onclave Therapeutics Ltd
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
CN108473932B (zh) * 2015-09-09 2022-07-15 集联健康有限公司 用于样品收集、稳定化和保存的系统、方法和装置
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
TW202425920A (zh) 2017-01-10 2024-07-01 美商集聯健康有限公司 筒匣組裝件
CN117050969B (zh) * 2023-08-18 2024-04-02 北京中检葆泰生物技术有限公司 一种碱性磷酸酶的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
CA1258428A (en) * 1984-06-28 1989-08-15 Nalinkant C. Damani Antacid composition
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
CA2031191C (en) * 1989-05-01 1997-03-25 Julian P. Breillatt, Jr. Composition of beneficial agent and method for administering the same by controlled dissolution
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
WO1993010758A1 (en) * 1991-12-05 1993-06-10 Pitman-Moore, Inc. A carbohydrate glass matrix for the sustained release of a therapeutic agent
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
AU2531295A (en) * 1994-05-27 1995-12-21 Farmarc Nederland Bv Pharmaceutical composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NONE *

Also Published As

Publication number Publication date
IL122482A0 (en) 1998-06-15
AP9701151A0 (en) 1998-01-31
JP4502406B2 (ja) 2010-07-14
DE69628007T2 (de) 2003-11-27
HUP9901716A3 (en) 2000-04-28
WO1996040077A3 (en) 1997-01-23
EP0831790A2 (en) 1998-04-01
JPH11506467A (ja) 1999-06-08
EP0831790B1 (en) 2003-05-07
MX9709716A (es) 1998-03-31
PL323902A1 (en) 1998-04-27
HUP9901716A2 (hu) 1999-09-28
DE69628007D1 (de) 2003-06-12
CZ391297A3 (cs) 1998-05-13
SK167597A3 (en) 1998-10-07
WO1996040077A2 (en) 1996-12-19
CN1245957C (zh) 2006-03-22
CA2223438C (en) 2008-05-13
PL184823B1 (pl) 2002-12-31
AU6009896A (en) 1996-12-30
CN1193908A (zh) 1998-09-23
KR19990022710A (ko) 1999-03-25
ATE239451T1 (de) 2003-05-15
ES2194992T3 (es) 2003-12-01
DK0831790T3 (da) 2003-09-01
BR9609188A (pt) 1999-05-11
NZ309841A (en) 1999-10-28
PT831790E (pt) 2003-07-31
IL122482A (en) 1999-10-28
NO975773D0 (no) 1997-12-08
NO975773L (no) 1998-02-03
CA2223438A1 (en) 1996-12-19
AU713599B2 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
AP852A (en) Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby.
US6964771B1 (en) Method for stably incorporating substances within dry, foamed glass matrices
US6503411B1 (en) Stable compositions
CN101039660B (zh) 稳定的聚乙二醇化干扰素制剂
US6811792B2 (en) Solid dose delivery vehicle and methods of making same
US6872357B1 (en) Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying
NO326966B1 (no) Partikkelpreparat for terapeutisk anvendelse, egnet for administrering ved inhalasjon, anordning for pulmonal avlevering av et terapeutisk middel, og fremgangsmate for fremstilling av partiklene
AU780602B2 (en) Preservation of sensitive biological material
US7153472B1 (en) Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
JP2006504801A (ja) 乾燥方法
EP1210361A1 (en) Stabilisation of freeze-dried cake
US5489577A (en) Semi-solid pharmaceutical agent and process for producing the same
US5384132A (en) Stabilized gonadotropin containing preparations
WO2001037804A2 (en) Preservation and formulation of bioactive materials
JP2002537322A (ja) 速可溶性組成物
WO2022116134A1 (zh) 磷苯妥英钠固体组合物、冻干方法、及其用途